41306-56-3

Upstream product

• 1207430-17-8 2-[3-(1-tosyl-1H-imidazol-2-yl)propyl]isoindoline-1,3-dione 

Downstream Products

• 90259-60-2 2-Amino-N-[3-(1H-imidazole-1-yl)propyl]benzamide 
• 1421593-57-8 N-(3-(1H-imidazol-1-yl)propyl)-1-(2,4-dichlorobenzyl)-1H-indazole-3-carboxamide 
• 1610840-31-7 (4R)-N-(3-(3-(1H-imidazol-1-yl)propylamino)-3-oxopropyl)-2-(4-methoxyphenyl)-5,5-dimethyl-1,3-dioxane-4-carboxamide 

Relevant academic research and scientific papers

BENZOIMIDAZOLE DERIVATIVES AND GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING THE SAME

Benzoimidazole Derivatives are provided. The compounds of the present invention are useful for Glycogen Synthase Kinase-3 Beta Inhibitors.

Oligomeric aminodiol-containing compounds, libraries thereof, and process of preparing the same

Oligomeric compounds comprising a plurality of aminodiol monomer subunits joined by linking groups are provided, as well as libraries of such compounds and processes for preparing the oligomeric compounds and libraries.

Method for inhibiting advanced glycosylation of proteins using aminosubstituted imidazoles

The present invention relates to compositions and methods for inhibiting nonenzymatic cross-linking (protein aging), Accordingly, a composition is disclosed which comprises 2-aminoimidazoles capable of inhibiting the formation of advanced glycosylation endproducts of target proteins by reacting with the carbonyl moiety of the early glycosylation product of such target proteins formed by their initial glycosylation, The method comprises contacting the target protein with the composition, Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.